{"id":8022,"date":"2024-07-17T10:10:51","date_gmt":"2024-07-17T08:10:51","guid":{"rendered":"https:\/\/www.rcts.fr\/real-life-omalizumab-exposure-and-discontinuation-2\/"},"modified":"2026-01-26T14:13:17","modified_gmt":"2026-01-26T13:13:17","slug":"real-life-omalizumab-exposure-and-discontinuation-2","status":"publish","type":"post","link":"https:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/","title":{"rendered":"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":7645,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[47,61],"class_list":["post-8022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-success-stories-en","category-immunology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Real-Life Omalizumab Exposure and Discontinuation: Key Insights<\/title>\n<meta name=\"description\" content=\"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real-Life Omalizumab Exposure and Discontinuation: Key Insights\" \/>\n<meta property=\"og:description\" content=\"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/\" \/>\n<meta property=\"og:site_name\" content=\"RCTs\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-17T08:10:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-26T13:13:17+00:00\" \/>\n<meta name=\"author\" content=\"Didier Not\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Didier Not\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/\"},\"author\":{\"name\":\"Didier Not\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\"},\"headline\":\"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)\",\"datePublished\":\"2024-07-17T08:10:51+00:00\",\"dateModified\":\"2026-01-26T13:13:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/\"},\"wordCount\":18,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-15.svg\",\"articleSection\":[\"Success stories\",\"Immunology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/\",\"url\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/\",\"name\":\"Real-Life Omalizumab Exposure and Discontinuation: Key Insights\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#primaryimage\"},\"image\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-15.svg\",\"datePublished\":\"2024-07-17T08:10:51+00:00\",\"dateModified\":\"2026-01-26T13:13:17+00:00\",\"description\":\"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-15.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/vignette-580x430-15.svg\",\"width\":434,\"height\":322,\"caption\":\"Real-Life Omalizumab Exposure and Discontinuation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.rcts.fr\\\/en\\\/real-life-omalizumab-exposure-and-discontinuation-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"name\":\"RCTs\",\"description\":\"Description\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rcts.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#organization\",\"name\":\"RCTs\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"contentUrl\":\"https:\\\/\\\/www.rcts.fr\\\/wp-content\\\/uploads\\\/logo-blue.svg\",\"width\":163,\"height\":47,\"caption\":\"RCTs\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rcts.fr\\\/#\\\/schema\\\/person\\\/19ff6b0ca72b83f30ac0a23e6ce05dc5\",\"name\":\"Didier Not\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g\",\"caption\":\"Didier Not\"},\"url\":\"https:\\\/\\\/www.rcts.fr\\\/en\\\/author\\\/dnorcts-fr\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real-Life Omalizumab Exposure and Discontinuation: Key Insights","description":"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/","og_locale":"en_US","og_type":"article","og_title":"Real-Life Omalizumab Exposure and Discontinuation: Key Insights","og_description":"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.","og_url":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/","og_site_name":"RCTs","article_published_time":"2024-07-17T08:10:51+00:00","article_modified_time":"2026-01-26T13:13:17+00:00","author":"Didier Not","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Didier Not","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#article","isPartOf":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/"},"author":{"name":"Didier Not","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5"},"headline":"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)","datePublished":"2024-07-17T08:10:51+00:00","dateModified":"2026-01-26T13:13:17+00:00","mainEntityOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/"},"wordCount":18,"publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"image":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-15.svg","articleSection":["Success stories","Immunology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/","url":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/","name":"Real-Life Omalizumab Exposure and Discontinuation: Key Insights","isPartOf":{"@id":"https:\/\/www.rcts.fr\/#website"},"primaryImageOfPage":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#primaryimage"},"image":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-15.svg","datePublished":"2024-07-17T08:10:51+00:00","dateModified":"2026-01-26T13:13:17+00:00","description":"Real-Life Omalizumab Exposure and Discontinuation in a large nationwide population-based study of paediatric and adult asthma patients.","breadcrumb":{"@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#primaryimage","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-15.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/vignette-580x430-15.svg","width":434,"height":322,"caption":"Real-Life Omalizumab Exposure and Discontinuation"},{"@type":"BreadcrumbList","@id":"http:\/\/www.rcts.fr\/en\/real-life-omalizumab-exposure-and-discontinuation-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rcts.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients (SOLAIR)"}]},{"@type":"WebSite","@id":"https:\/\/www.rcts.fr\/#website","url":"https:\/\/www.rcts.fr\/","name":"RCTs","description":"Description","publisher":{"@id":"https:\/\/www.rcts.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rcts.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rcts.fr\/#organization","name":"RCTs","url":"https:\/\/www.rcts.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","contentUrl":"https:\/\/www.rcts.fr\/wp-content\/uploads\/logo-blue.svg","width":163,"height":47,"caption":"RCTs"},"image":{"@id":"https:\/\/www.rcts.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rcts.fr\/#\/schema\/person\/19ff6b0ca72b83f30ac0a23e6ce05dc5","name":"Didier Not","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/384084503863c2fae1497cd4aff02d7d7ec7ec0d357eb358655b55a5dd586850?s=96&d=mm&r=g","caption":"Didier Not"},"url":"https:\/\/www.rcts.fr\/en\/author\/dnorcts-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/8022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/comments?post=8022"}],"version-history":[{"count":2,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/8022\/revisions"}],"predecessor-version":[{"id":8030,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/posts\/8022\/revisions\/8030"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media\/7645"}],"wp:attachment":[{"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/media?parent=8022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rcts.fr\/en\/wp-json\/wp\/v2\/categories?post=8022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}